Charis Himeda talks about CRISPR and FSH muscular dystrophy

From the FSHD Society’s webinar series on facioscapulohumeral muscular dystrophy. Charis Himeda, PhD, of the University of Nevada Reno, discusses her groundbreaking work showing how CRISPR “gene editing” technology can be used to repress the DUX4 gene implicated in FSHD, and answers questions from the audience.

Check out her video below. If you have further questions, you can post them in the Comments section and we will forward them to Dr. Himeda.


One response to “Charis Himeda talks about CRISPR and FSH muscular dystrophy”

Leave a Reply

Your email address will not be published. Required fields are marked *